Pioglitazone add-on therapy in patients with type 2 diabetes effective and safe option for better glycemic control: Study Medha Baranwal10 April 2024 10:00 AM ISTSouth Korea: Adjunctive pioglitazone therapy in type 2 diabetes mellitus (T2DM) inadequately controlled with dapagliflozin and metformin yielded...
Evergreen Talk Series: How can Safety and Tolerability of Linagliptin and Dapagliflozin benefit diverse T2DM population? MD Brand Connect25 March 2024 4:38 PM ISTPresenting the Evergreen Talk Series featuring Dr. Brij Mohan Makkar, a Senior Diabetologist and Obesity Specialist from Delhi, Dr Sameer I. Dani, an...
Finerenone and dapagliflozin combo significantly reduced albuminuria in non-diabetic CKD patients: Study Aditi20 March 2024 7:30 PM ISTThe effectiveness of dapagliflozin and finerenone in reducing albuminuria and slowing the progression of chronic kidney disease (CKD) has been...
Synokem gets CDSCO Panel Nod To Study FDC Dapagliflozin plus Sacubitril plus Valsartan Dr. Divya Colin10 March 2024 5:30 PM ISTNew Delhi: The drug major Synokem Pharmaceutical has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
AstraZeneca gets CDSCO Panel Nod To update Prescribing Information of Antidiabetic FDC Dr. Divya Colin7 March 2024 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has granted approval to...
EVERGREEN Webinar: Clinical FAQs on T2DM Care, Addressed by Dr V Mohan Dr Jeegar Dattani6 March 2024 12:29 PM ISTThe Evergreen webinar addressed the clinical applicability of Linagliptin and Dapagliflozin in real-world clinical scenarios of type 2 diabetes....
Evergreen Talk Series: Combination of Linagliptin and Dapagliflozin in T2DM with multiple episodes of hypoglycemia MDTV Bureau21 Feb 2024 9:30 AM ISTPresenting the Evergreen Talk Series featuring Dr. Brij Mohan Makkar, a Senior Diabetologist and Obesity Specialist from Delhi, Dr Sameer I. Dani, an...
Dapagliflozin leads to modest reduction in systolic BP in patients with CKD and albuminuria: Study Medha Baranwal21 Feb 2024 3:00 AM ISTUSA: Treatment with dapagliflozin in patients with chronic kidney disease (CKD) and albuminuria is associated with modest but clinically meaningful...
Akums Gets CDSCO Panel Nod To Manufacture, Market Antidiabetic FDC Drug Dr. Divya Colin13 Feb 2024 6:00 PM ISTNew Delhi: The drug major Akum Pharmaceutical has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Top 10 Messages from Evergreen Webinar on Clinical Applicability of Linagliptin Dapagliflozin in Type 2 Diabetes, Addressed by Dr V Mohan Dr Jeegar Dattani12 Feb 2024 12:15 PM ISTDr. V. Mohan, M.D., FRCP (London, Edinburgh, Glasgow & Ireland), Ph.D., D.Sc. D.Sc (Hon. Causa), FNASc, FASc, FNA, FACE, FACP, FTWAS, MACP, FRSE....
Dapagliflozin therapy helps reduce CV mortality in heart failure with improved ejection fraction: JAMA Medha Baranwal1 Feb 2024 11:00 AM ISTUSA: Adding a sodium-glucose transport protein 2 inhibitor therapy to other guideline-directed medical therapies may help lower cardiovascular...
Evergreen Talk Series: Use of SGLT2i and DPP4i combination in T2DM patients with a history of Genitourinary Tract Infections MD Brand Connect1 Feb 2024 10:30 AM ISTPresenting the Evergreen Talk Series featuring Dr. Brij Mohan Makkar, a Senior Diabetologist and Obesity Specialist from Delhi, Dr Sameer I. Dani,...
